AU2003298035A1 - Compositions and methods for inhibiting malaria protease falcipain-2 - Google Patents

Compositions and methods for inhibiting malaria protease falcipain-2

Info

Publication number
AU2003298035A1
AU2003298035A1 AU2003298035A AU2003298035A AU2003298035A1 AU 2003298035 A1 AU2003298035 A1 AU 2003298035A1 AU 2003298035 A AU2003298035 A AU 2003298035A AU 2003298035 A AU2003298035 A AU 2003298035A AU 2003298035 A1 AU2003298035 A1 AU 2003298035A1
Authority
AU
Australia
Prior art keywords
compositions
methods
inhibiting malaria
falcipain
protease falcipain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003298035A
Other versions
AU2003298035A8 (en
Inventor
Athar H. Chishti
Manjit Hanspal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
St Elizabeths Medical Center of Boston Inc
Original Assignee
St Elizabeths Medical Center of Boston Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Elizabeths Medical Center of Boston Inc filed Critical St Elizabeths Medical Center of Boston Inc
Publication of AU2003298035A1 publication Critical patent/AU2003298035A1/en
Publication of AU2003298035A8 publication Critical patent/AU2003298035A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2003298035A 2002-12-06 2003-12-05 Compositions and methods for inhibiting malaria protease falcipain-2 Abandoned AU2003298035A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43129402P 2002-12-06 2002-12-06
US60/431,294 2002-12-06
PCT/US2003/038835 WO2004052914A2 (en) 2002-12-06 2003-12-05 Compositions and methods for inhibiting malaria protease falcipain-2

Publications (2)

Publication Number Publication Date
AU2003298035A1 true AU2003298035A1 (en) 2004-06-30
AU2003298035A8 AU2003298035A8 (en) 2004-06-30

Family

ID=32507704

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003298035A Abandoned AU2003298035A1 (en) 2002-12-06 2003-12-05 Compositions and methods for inhibiting malaria protease falcipain-2

Country Status (2)

Country Link
AU (1) AU2003298035A1 (en)
WO (1) WO2004052914A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017518514A (en) * 2014-05-16 2017-07-06 インターミューン， インコーポレイテッド LPA-related protein and RNA expression
CN110297095A (en) * 2019-07-26 2019-10-01 四川农业大学 A kind of screening technique of insect allergic protein

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225086B1 (en) * 1997-05-21 2001-05-01 Yale University Polynucleotides encoding ankyrin proteins

Also Published As

Publication number Publication date
WO2004052914A2 (en) 2004-06-24
WO2004052914A3 (en) 2004-12-29
AU2003298035A8 (en) 2004-06-30
WO2004052914A8 (en) 2004-10-14

Similar Documents

Publication Publication Date Title
AU2003202263A1 (en) Roh-kinase inhibitors
AU2002357119A1 (en) Mitocidal compositions and methods
AU2003298514A1 (en) Methods and compositions using cholinesterase inhibitors
AU2003262747A1 (en) Compounds, compositions, and methods
AU2003259749A1 (en) 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
AU2003236527A1 (en) Compounds, compositions, and methods
AU2003265242A1 (en) Compounds, compositions, and methods
AU2003270015A1 (en) Compounds, compositions, and methods
AU2003213776A1 (en) Carbamates as hiv protease inhibitors
AU2003256805A1 (en) Compounds compositions and methods
AU2003299612A1 (en) Compounds, compositions and methods
AU2003249683A1 (en) Nf-:b inhibitors
AU2003286486A1 (en) Methods and compositions for immunization against hiv
AU2003290507A1 (en) Compounds, compositions and methods
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2003277079A1 (en) Compounds, compositions, and methods
AU2003269904A1 (en) Antigen-polymer compositions
AU2003269984A1 (en) Protease inhibitors
AU2003295574A1 (en) Method and compositions for temporarily incapaciting subjets
AUPS317102A0 (en) Transdermal aerosol compositions
AU2002351200A1 (en) Compositions and methods for inhibiting prenyltransferases
AU2002366809A1 (en) Syn3 compositions and methods
AU2003300031A1 (en) Compounds, compositions, and methods
AU2003267169A1 (en) Compounds, compositions and methods
AU2002310046A1 (en) Compositions and methods for inhibiting metastasis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase